Mechanically, LDA directly targets TRAF2 and disrupts TRAF2/β-catenin/TCF4/TNIK complex formation, thereby inhibiting WNT/β-catenin signaling in CRC [157]. The gene discussed is TRAF2; the disease is colorectal carcinoma.